GGO Vergunningendatabase

Zoekcriteria
Zoekresultaat
IM-MV 24-014_000 Amsterdam UMC Human Clinical Studies of TCR-T Therapy (Autologous TCRModified T-Cell Therapy) Targeting Tumour Antigens in Solid Tumours with Specific mutation(s) and Human Leukocyte Antigen (HLA) Genotypes 22-01-2025 Vergunning verleend
IM-MV 24-020_000 Universitair Medisch Centrum Utrecht A Phase 3, Randomized, Open-Label, Multicenter Study to Compare the Efficacy and Safety of BMS-986393, a GPRC5D-directed CAR-T Cell Therapy, Versus Standard Regimens in Adult Participants with Relapsed or Refractory and Lenalidomide-refractory Multiple Myeloma Ontwerpbesluit genomen